Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's No Comment On Budget Plans Leaves Awkward Void

Executive Summary

When asked about the effect of Trump's potential cuts to FDA, agency officials are not allowed to discuss it, creating more uncertainty about the budget and user fee process.

Advertisement

Related Content

Capitol Hill Update: Congress Gets Reprieve On User Fee Passage, While AdvaMed Weighs Device Tax Options
FDA Gives Congress Reprieve On Deadline For Passing User Fee Bill
FDA Gives Congress Reprieve On Deadline For Passing User Fee Bill
User Fee Bill Caught In Comey Firing Tidal Wave
User Fee Bill Caught In Comey Firing Tidal Wave
Current FDA Policy Uncertainties Could Yield 'Reverse Impact' Of Support
The Freeze Thaws: US FDA Allowed To Hire Staff For Cures, User Fee Activity
Trump's Budget Outline Threatens User Fee Agreements
Woodcock Tries To Calm US FDA Staff Fears About Trump
FDA Budget Request Is Flat For Drugs, Pressuring Stakeholders

Topics

Advertisement
UsernamePublicRestriction

Register

PS120297

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel